Accsys, the fast-growing company that enhances the natural properties of wood to make high performance and sustainable building products, is pleased to announce the following appointments to its Board of Directors.
Appointment of Non-Executive Chair of Accsys
Further to the announcement on 12 September 2023, Accsys announces that the Board has appointed Trudy Schoolenberg as permanent Non-Executive Chair of Accsys after due process, including consultation with shareholders. Beyond her extensive experience with the Accsys business over the past five years, her appointment as Chair will contribute further stability and continuity to the Board. Trudy will also be appointed Chair of the Nomination Committee. Both her appointments will be effective from 12 December 2023.
Trudy was announced Interim Chair on 12 September 2023 having joined the Accsys Board as a Senior Independent Director in April 2018. Trudy has almost 30 years of experience working for blue-chip companies in the chemicals, engineering and high-performance product sectors. She spent over 20 years with Royal Dutch Shell where she led in R&D, operations and business strategy. She continued her career leading R&D in Wartsila, a blue-chip Finland based engineering company. Later she moved to AKZO Nobel decorative paints, where she was global Director for R&D, Manufacturing and Supply Chain. Trudy has over 10 years of experience as a Non-Executive Director for UK plc businesses, including roles as Senior Independent Director at Spirax Sarco Engineering plc, Elementis plc and TI Fluid Systems plc.
Appointment of Edwin Bouwman
In addition, Accsys announces the appointment of Edwin Bouwman as a Non-Executive Director with effect from 12 December 2023. Edwin has been appointed by Teslin Participaties Coöperatief U.A. and "De Engh" B.V. under the terms of a Relationship Agreement dated 21 November 2023 and he will consequently be classified as non-independent. Edwin will also be a member of the Audit and Remuneration Committees.
Edwin brings over 30 years of experience in the energy and building materials industry and has held executive roles at both public and private multinational companies, including Royal Dutch Shell, Roto Smeets NV, CRH Plc and SHV Energy. During his career Edwin has established a track record of successful business transformation, delivering both organic and acquisitive growth strategies to enable substantial portfolio performance improvement.
Edwin currently serves as Non-Executive Director of Intergamma Coöperatief U.A where he is Chair of the Risk and Audit committee, and CliniClowns where he is Chair of the charity's Audit Committee.
Trudy Schoolenberg, Chair of Accsys, commented:
"I am delighted to have been appointed as Chair of Accsys. I am also pleased to welcome Edwin to the Board and we look forward to benefitting from his highly relevant experience. As I look ahead I believe Accsys is a business with tremendous opportunity, able to navigate the near-term market challenges and capable of meeting its significant potential. I look forward to supporting our CEO, Dr. Jelena Arsic van Os and the wider team in my role as Chair."
Dr. Jelena Arsic van Os, Chief Executive Officer of Accsys, added:
"I am very pleased with the appointments of Trudy Schoolenberg as Chair and Edwin Bouwman as Non-Executive Director given their strong industry knowledge. I am confident that the Accsys Board will benefit greatly from their sector experience and background."
The following information is disclosed in accordance with paragraph (g) of Schedule Two of the AIM Rules for Companies in relation to Edwin Bouwman's appointment to the Board as Non-Executive Director:
Full name: Edwin Henricus Odette Maria Bouwman
Age: 56 years
Current Directorships: Intergamma Coöperatief U.A., Stichting CliniClowns Nederland, Badhuis Holding B.V., Badhuis Management Services B.V.
Directorships held in the past five years: CRH Nederland B.V., Calor Group Limited, Liquigas S.p.A., SHK Grundstucks GmbH, CRH Deutschland GmbH, CRH Grundbesitz GmbH.
There are no other matters in relation to the appointment of Edwin Bouwman which are required to be disclosed in accordance with the AIM Rules for Companies.
Edwin Bouwman holds no shares in Accsys.